🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in India / NCT07241390
Recruiting Phase 3

A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)

NCT07241390 · tracked via the Priya Life Science India tracker
Sponsor
Eli Lilly and Company
Phase
Phase 3
Started
2025-12-01
Last updated
2026-09-08

Condition(s) studied

Atherosclerosis Cardiovascular DiseaseChronic Kidney Disease

Investigational drug(s) / intervention(s)

OrforglipronPlacebo

Orforglipron: Administered orally

Placebo: Administered orally

Study summary

The purpose of this study is to measure cardiovascular outcomes with orforglipron compared with placebo in participants with atherosclerotic cardiovascular disease (ASCVD) and/or chronic kidney disease (CKD). Participation in the study will last about 5 years.

Eligibility

Sex
ALL
Min age
50 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Have established ASCVD and/or CKD Exclusion Criteria: * Have type 1 diabetes * Have had a major heart condition within 60 days prior to screening * Have New York Heart Association Functional Classification Class IV heart failure

Primary outcome measure(s)

Trial sites (566)

FacilityCityRegionStatus
Instituto de Investigaciones Clínicas Bahia Blanca Bahía Blanca Argentina Recruiting
CONEXA Investigacion Clinica S.A. Buenos Aires Argentina Recruiting
Buenos Aires Macula S.A Buenos Aires Argentina Recruiting
CIPREC Buenos Aires Argentina Recruiting
Instituto Médico Especializado (IME) Buenos Aires Argentina Recruiting
Cicemo Srl Buenos Aires Argentina Recruiting
Cardiología Palermo Buenos Aires Argentina Recruiting
Consultorio Medico Investigador Principal Dr Besada Buenos Aires Argentina Recruiting
Glenny Corp. S.A. Buenos Aires Argentina Recruiting
Organizacion Medica de Investigacion Buenos Aires Argentina Recruiting
Stat Research S.A. Buenos Aires Argentina Recruiting
Investigaciones Medicas Imoba Srl Buenos Aires Argentina Recruiting
Centro de Investigaciones Metabólicas (CINME) Buenos Aires Argentina Recruiting
CIPREC Buenos Aires Argentina Recruiting
Centro Médico Viamonte Buenos Aires Argentina Recruiting
Mautalen Salud e Investigación Buenos Aires Argentina Recruiting
CEMEDIC Buenos Aires Argentina Recruiting
Centro Medico Dra. Laura Maffei- Investigacion Clinica Aplicada Buenos Aires Argentina Recruiting
Fundación Respirar Buenos Aires Argentina Recruiting
CEMEDIAB C.a.b.a. Argentina Recruiting
CEDIC CABA Argentina Recruiting
Instituto de Cardiología "Juana F. Cabral" Corrientes Argentina Recruiting
Centro Diabetológico Dr. Waitman Córdoba Argentina Recruiting
Instituto de Investigaciones Clínicas Córdoba Córdoba Argentina Recruiting
Centro Medico Privado San Vicente Diabetes Córdoba Argentina Recruiting
Instituto Médico DAMIC Córdoba Argentina Recruiting
Hospital Italiano de Córdoba Córdoba Argentina Recruiting
Sanatorio Esperanza Esperanza Argentina Recruiting
CIPADI - Centro Integral de Prevencion y Atencion en Diabetes Godoy Cruz Argentina Recruiting
Centro de Investigaciones Clínicas Baigorria Granadero Baigorria Argentina Recruiting
Centro de Salud Renal Junín Junín Argentina Recruiting
CIMeL Lanus Argentina Recruiting
Centro de Investigaciones Médicas Mar del Plata Mar del Plata Argentina Recruiting
Instituto de Investigaciones Clínicas Mar del Plata Mar del Plata Argentina Recruiting
Instituto de Cardiología Wolff Mendoza Argentina Recruiting
CER medical Institute Quilmes Argentina Recruiting
DIM Clínica Privada Ramos Mejía Argentina Recruiting
Instituto Médico Río Cuarto Río Cuarto Argentina Recruiting
Fundacion Estudios Clinicos Rosario Argentina Recruiting
Fundación Innovaciencia Rosario Argentina Recruiting

+ 526 more sites — see the full list on the official registry below.

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07241390 on ClinicalTrials.gov ↗ ← All trials in India